Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk

NCT02634333 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT02634333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02634333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2016
Completion date
May 11, 2022
Enrollment
399 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy